Barbara L. Weber

Affiliations: 
University of Pennsylvania, Philadelphia, PA, United States 
Area:
Genetics, Cell Biology, Molecular Biology
Google:
"Barbara Weber"
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Barretina J, Caponigro G, Stransky N, et al. (2012) The Cancer Cell Line Encyclopedia enables predictive modelling of anticancer drug sensitivity. Nature. 483: 603-7
Maxwell CA, Benítez J, Gómez-Baldó L, et al. (2011) Interplay between BRCA1 and RHAMM regulates epithelial apicobasal polarization and may influence risk of breast cancer. Plos Biology. 9: e1001199
Huang J, Zhang L, Greshock J, et al. (2011) Frequent genetic abnormalities of the PI3K/AKT pathway in primary ovarian cancer predict patient outcome. Genes, Chromosomes & Cancer. 50: 606-18
Johannessen CM, Boehm JS, Kim SY, et al. (2010) COT drives resistance to RAF inhibition through MAP kinase pathway reactivation. Nature. 468: 968-72
Gilbert PM, Mouw JK, Unger MA, et al. (2010) HOXA9 regulates BRCA1 expression to modulate human breast tumor phenotype. The Journal of Clinical Investigation. 120: 1535-50
Heiser LM, Wang NJ, Talcott CL, et al. (2009) Integrated analysis of breast cancer cell lines reveals unique signaling pathways. Genome Biology. 10: R31
Ma C, Quesnelle KM, Sparano A, et al. (2009) Characterization CSMD1 in a large set of primary lung, head and neck, breast and skin cancer tissues. Cancer Biology & Therapy. 8: 907-16
Flaherty KT, Schiller J, Schuchter LM, et al. (2008) A phase I trial of the oral, multikinase inhibitor sorafenib in combination with carboplatin and paclitaxel. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 4836-42
LoRusso PM, Jones SF, Koch KM, et al. (2008) Phase I and pharmacokinetic study of lapatinib and docetaxel in patients with advanced cancer. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 26: 3051-6
Zhang L, Volinia S, Bonome T, et al. (2008) Genomic and epigenetic alterations deregulate microRNA expression in human epithelial ovarian cancer. Proceedings of the National Academy of Sciences of the United States of America. 105: 7004-9
See more...